Stockscreener 앱 받기
160.97
3.15%
-5.24
시간 외 거래:
160.30
-0.67
-0.42%
전일 마감가:
$166.21
열려 있는:
$167.845
하루 거래량:
1.50M
Relative Volume:
0.91
시가총액:
$24.35B
수익:
$4.39B
순이익/손실:
$853.00M
주가수익비율:
29.22
EPS:
5.5097
순현금흐름:
$556.00M
1주 성능:
-0.83%
1개월 성능:
+10.48%
6개월 성능:
+19.35%
1년 성능:
+82.65%
1일 변동 폭
$159.34
$168.00
1주일 범위
$155.55
$168.00
52주 변동 폭
$85.77
$177.22
일루미나 Stock (ILMN) Company Profile
명칭
Illumina Inc
전화
(858) 202-4500
주소
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
160.97 | 24.35B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
469.34 | 174.42B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
180.10 | 127.47B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.88 | 44.24B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
129.84 | 36.67B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
355.53 | 34.91B | 3.77B | 449.25M | 240.68M | 7.8556 |
일루미나 Stock (ILMN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-12 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | 재확인 | Citigroup | Neutral |
| 2025-02-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-02-10 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2025-02-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-11-12 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-10-17 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-08-28 | 업그레이드 | Argus | Hold → Buy |
| 2024-08-16 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-08-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-01-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-12-11 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-11-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | 개시 | Bernstein | Underperform |
| 2023-07-05 | 재개 | JP Morgan | Neutral |
| 2023-01-25 | 다운그레이드 | Argus | Buy → Hold |
| 2023-01-05 | 개시 | Scotiabank | Sector Perform |
| 2022-12-12 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-04 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-07-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-18 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-19 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | 업그레이드 | Evercore ISI | Underperform → In-line |
| 2021-03-31 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | 개시 | Barclays | Underweight |
| 2020-12-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-10-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-09-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-09-21 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-09-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-08-07 | 다운그레이드 | Evercore ISI | In-line → Underperform |
| 2020-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-10-25 | 개시 | Guggenheim | Buy |
모두보기
일루미나 주식(ILMN)의 최신 뉴스
Illumina Inc. Stock (US4523271090): shares steady as investors await next earnings catalyst - AD HOC NEWS
Liquidity Mapping Around (ILMN) Price Events - Stock Traders Daily
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina Inc (ILMN) Stock Down 3.1% but Still Overvalued -- GF S - GuruFocus
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
When sequencing isn’t enough: A global forum for finding answers - Illumina
Illumina Stock’s Operating Margin Climbs to 22% in Q1 2026: Is it Enough to Support a $300 Target? - TIKR.com
Fox Run Management L.L.C. Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
Loomis Sayles Growth Portfolio's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina stock upgraded at J.P. Morgan (ILMN:NASDAQ) - Seeking Alpha
Illumina (NASDAQ:ILMN) Shares Gap Up After Analyst Upgrade - MarketBeat
JPMorgan Upgrades Illumina to Overweight From Neutral, Price Target is $185 - marketscreener.com
Amova Asset Management Americas Inc. Reduces Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Insider Sell: Patricia Leckman Sells Shares of Illumina Inc (ILM - GuruFocus
Illumina SVP Patricia Leckman sells $127,304 in company stock - Investing.com UK
Illumina SVP Patricia Leckman sells $127,304 in company stock By Investing.com - Investing.com South Africa
Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Illumina (ILMN): Bullish Structure Builds After Breakout - FXEmpire
Illumina (ILMN) Chief People Officer sells 783 common shares - Stock Titan
Illumina Inc. stock (US4523271090): new StrataMap launch after strong 12?month rally - AD HOC NEWS
Templeton Global Smaller Companies Fund's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Illumina launches StrataMap Spatial Solution, a powerful end-to- - GuruFocus
8 Cancer organizations receive grants to expand access to genomic testing - Illumina
Illumina Launches StrataMap Spatial Solution for Whole Transcriptome Analysis - geneonline.com
Illumina launches StrataMap Spatial research solution By Investing.com - Investing.com Canada
Illumina launches StrataMap Spatial research solution - Investing.com
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution - PR Newswire
Why Grail Could Be the Sleeper Stock Everyone's About to Notice - The Motley Fool
Capital International Inc. CA Boosts Stock Position in Illumina, Inc. $ILMN - MarketBeat
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Illumina (ILMN) Valuation Check After New Oncology Collaborations And MRD Research Launch - Yahoo Finance
Illumina, Inc. $ILMN Shares Sold by Capital International Ltd. CA - MarketBeat
Capital World Investors Boosts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Capital International Sarl Sells 15,683 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Bank of New York Mellon Corp - MarketBeat
Illumina (Nasdaq: ILMN) Form 144 lists proposed sale by trust - Stock Titan
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina (ILMN) chief people officer sells 784 shares in open market - Stock Titan
What is multiomics? A simple guide to the future of biology - Illumina
Illumina, Inc. (NASDAQ:ILMN) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Illumina Inc. stock (US4523271090): shares edge higher on Nasdaq amid focus on sequencing demand and - AD HOC NEWS
Illumina jumps as bullish analyst note extends optimism around clinical sequencing momentum - Quiver Quantitative
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge? - TradingView
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina, Inc. Hits New 52-Week High of $165.93, Up 54% - Markets Mojo
Illumina, Inc. Hits New 52-Week High at USD 165.37 - Markets Mojo
Illumina, Inc. Hits New 52-Week High of $158.78, Up 48.7% - Markets Mojo
[144] ILLUMINA, INC. SEC Filing - Stock Titan
Frances Arnold reports proposed sale of 5,000 shares | ILMN SEC FilingForm 144 - Stock Titan
IDT partners with Illumina on oncology research workflow - Investing.com UK
일루미나 (ILMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.22%
자본화:
|
볼륨(24시간):